摘要
目的:观察麦滋林-s加雷尼替丁治疗消化性溃疡的疗效。方法:经胃镜确诊的消化性溃疡87例,随机分为治疗组(男性40例,女性7例,年龄38±s14a)餐前冲服麦滋林-s0.67g,tid,加雷尼替丁胶囊150mg,bid;对照组(男性37例,女性3例,年龄38±13a)单用雷尼替丁150mg,po,bid。疗程均为4~6wk。结果:消化性溃疡治疗4wk和6wk的愈合率,治疗组是62%和96%,对照组是30%和85%,2组4wk和6wk的愈合率相比P<0.05和P>0.05。症状消失时间依次为8±3d和13±3d,P<0.01。治疗后9~12mo溃疡复发率依次为6%和15%。结论:麦滋林-s加雷尼替丁治疗消化性溃疡较单用雷尼替丁的效果好。
AIM: To evaluate the effect of Marzulene-s plus ranitidine in the treatment of peptic ulcer. METHODS: The 87 patients with peptic ulcer diagnosed with gastroscope were divided into 2 groups at random. The treatment group (M 40, F 7, age 38±s 14 a) were given Marzulene-s 0.67 g, po, tid before meal and ranitidine 150 mg po bid. The control group (M 37, F 3, age 38±13 a) took only ranitidine 150 mg, bid. The therapeutic course were 4-6 wk. RESULTS: The cure rates of the 2 groups were 62% and 30% after 4 treatment wk, and 96% and 85% after 6 treatment wk, respectively. The duration of disappearance of symptom were 8±3 d and 13±3 d, respectively. The recurrent rates of 9-12 mo after the treatment completion were 6% and 15%, respectively. Adverse reactions were mild. CONCLUSION: the combination of Marzulene-s with ranitidine was more effective than ranitidine alone in the treatment of peptic ulcer.
出处
《新药与临床》
CSCD
北大核心
1997年第2期77-78,共2页
关键词
消化性溃疡
麦滋林-S
雷尼替丁
药物疗法
peptic ulcer
Marzulene-s
ranitidine
gastroscopy
combination drug therapy